NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) click to participate
NGM has agreed to be acquired by affiliates of The Column Group. Under the agreement, shareholders of NGM will be entitled to $1.55 per ...